Pertussis in India: Past, Present, and Future
Authors:
- 16 December 2022
- journal article
- review article
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 90 (4) , 393-399
Abstract
While vaccines have markedly reduced the incidence of pertussis, a resurgence has occurred in many countries. Until recently, pertussis has not been recognized as an important public health challenge in India due to its successful infant immunization program. However, India still accounts for a large proportion of the world’s cases, and increasing reports of pertussis in other countries and in neonates have regenerated interest in pertussis among Indian authorities. The Global Pertussis Initiative (GPI) Annual Meeting was held virtually in October 2020, in part, to gain a better understanding of the epidemiology and disease burden of pertussis and to explore opportunities to improve its prevention in India. There was a consensus that pertussis cases are being underestimated in India due to multiple factors, such as a reliance on passive surveillance and diagnostic challenges. India offers both whole-cell pertussis and acellular pertussis vaccines, but vaccine coverage is inconsistent across regions due to differences in vaccine availability, access to health care, and regional administrative challenges. This report summarizes the outcomes and considers the key clinical implications of this meeting. The GPI agreed that active surveillance of pertussis in India would be optimal and recommended several studies, including serosurveillance among women of reproductive age to assess the prevalence of recent pertussis infection and to enable policy changes that will enhance the rational use of acellular and whole-cell vaccines. It also recommended engagement with nongovernmental organizations in order to encourage pregnancy immunization in the public sector. To achieve effective control of pertussis in the future, the GPI recognizes there are opportunities to characterize the burden of pertussis in India appropriately and increase vaccination coverage in multiple age groups.Keywords
This publication has 22 references indexed in Scilit:
- Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT)PLOS ONE, 2018
- Is There a Need for a Stand-alone Acellular Pertussis Vaccine?The Pediatric Infectious Disease Journal, 2018
- Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice with Bordetella pertussisThe Journal of Immunology, 2017
- Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccineVaccine, 2017
- What Is Wrong with Pertussis Vaccine Immunity?Cold Spring Harbor Perspectives in Biology, 2017
- Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthoodCellular Immunology, 2016
- Roads to the development of improved pertussis vaccines paved by immunologyPathogens and Disease, 2015
- Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with VaccinationmBio, 2014
- Summary of Notifiable Diseases - United States, 2011.2013
- Waning Immunity to Pertussis Following 5 Doses of DTaPPediatrics, 2013